标题
Cross-protection against drifted influenza viruses
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 9, Issue 3, Pages 582-590
出版商
Informa UK Limited
发表日期
2013-01-26
DOI
10.4161/hv.23239
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enhancement of DNA Vaccine Potency through Coadministration of CIITA DNA with DNA Vaccines via Gene Gun
- (2014) D. Kim et al. JOURNAL OF IMMUNOLOGY
- Acceptance and Safety of the Intradermal Influenza Vaccine Among the Elderly in Italy: an On-Field National Study
- (2012) Paolo Durando et al. ADVANCES IN THERAPY
- Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
- (2012) S. Mannino et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
- (2012) J. E. Ledgerwood et al. Clinical and Vaccine Immunology
- A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season
- (2012) Danuta M. Skowronski et al. CLINICAL INFECTIOUS DISEASES
- The future of human DNA vaccines
- (2012) Lei Li et al. JOURNAL OF BIOTECHNOLOGY
- Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes
- (2012) S. M. Patel et al. JOURNAL OF INFECTIOUS DISEASES
- Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
- (2012) Filippo Ansaldi et al. VACCINE
- Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin
- (2012) Xiaoyu Liu et al. VACCINE
- Induction of a cross-reactive antibody response to influenza virus M2 antigen in pigs by using a Sendai virus vector
- (2012) Hirokazu Hikono et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
- (2012) Giancarlo Icardi et al. Human Vaccines & Immunotherapeutics
- MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response
- (2011) Fajian Hou et al. CELL
- Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults
- (2011) Filippo Ansaldi et al. Expert Review of Vaccines
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults
- (2011) Robert W. Frenck et al. VACCINE
- Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
- (2010) Vincenzo Baldo et al. Clinical & Developmental Immunology
- MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
- (2010) Paolo Durando et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial
- (2010) Robert Arnou et al. Human vaccines & immunotherapeutics
- Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
- (2010) A. D. Cristillo et al. JOURNAL OF GENERAL VIROLOGY
- Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
- (2010) J. M. Luke et al. JOURNAL OF VIROLOGY
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
- (2010) C.-J. Wei et al. SCIENCE
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
- (2010) Filippo Ansaldi et al. VACCINE
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
- Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
- (2009) Daniel Wai-Sing Chu et al. VACCINE
- Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection
- (2009) Filippo Ansaldi et al. VACCINE
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
- (2009) François Roman et al. VACCINE
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
- (2009) Isabel Leroux-Roels et al. VACCINE
- Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
- (2008) Jean-François Nicolas et al. Expert Review of Vaccines
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial
- (2008) David Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
- (2008) Isabel Leroux-Roels et al. PLoS One
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
- (2008) Hans C. Rümke et al. VACCINE
- Safety of MF59™ adjuvant
- (2008) Viola Schultze et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started